• Something wrong with this record ?

Meeting report: 36th International Conference on Antiviral Research in Lyon, France - March 13-17, 2023

JR. Spengler, K. Carter, L. Delang, D. Durantel, BB. Gowen, LJ. Herrero, B. Hurst, Z. Janeba, R. Jordan, D. Luo, C. Meier, J. Moffat, J. Rocha-Pereira, KL. Seley-Radtke, SR. Welch, LM. Schang

. 2023 ; 217 (-) : 105678. [pub] 20230724

Language English Country Netherlands

Document type Congress, Journal Article, Review

The 36th International Conference on Antiviral Research (ICAR), sponsored by the International Society for Antiviral Research (ISAR), was held March 13-17, 2023, in Lyon, France, and concurrently through an interactive remote meeting platform. Here we provide a report summarizing the presentations at the 36th ICAR, including the ISAR speaker awards. We also detail special events, sessions, and additional awards conferred at the meeting. ICAR returned to in-person meetings in 2022, convening in Seattle, WA, USA. The 36th ICAR is the first in-person meeting of the society in Europe since the beginning of the COVID-19 pandemic, which restricted most events to virtual attendance to help mitigate the spread and subsequent public health impact of SARS-CoV-2. An exceptionally high number of registrants and record attendance at this year's ICAR, along with a vast array of demonstrable expertise in a variety of antiviral research-related fields, reflected a strong and growing antiviral research community committed to improving health outcomes from viral diseases, including SARS-CoV-2, and to future pandemic preparedness. This report highlights the breadth of expertise, quality of research, and notable advancements that were contributed by members of ISAR and other participants at the meeting. ICAR aims to continue to provide a platform for sharing information, fostering collaborations, and supporting trainees in the field of antiviral research. The 37th ICAR will be held in Gold Coast, Australia, May 20-24, 2024.

Baker Institute and Department of Microbiology and Immunology Cornell University Ithaca NY USA

Centre International de Recherche en Infectiologie Inserm_U1111 CNRS_UMR5308 Université Claude Bernard Lyon 1 F 69007 Lyon France

Department of Chemistry and Biochemistry University of Maryland Baltimore County Baltimore MD USA

Department of Microbiology and Immunology SUNY Upstate Medical University Syracuse NY USA

Evotec US Princeton NJ USA

Global Health Discovery and Translational Sciences Bill and Melinda Gates Foundation Seattle WA USA

Institute for Antiviral Research and Department of Animal Dairy and Veterinary Sciences Utah State University Logan UT USA

Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences Flemingovo nám 2 Prague Czech Republic

KU Leuven Department of Microbiology Immunology and Transplantation Rega Institute Laboratory of Virology and Chemotherapy Leuven Belgium

Laboratory of Virology and Chemotherapy Mosquito Virology Team KU Leuven Department of Microbiology Immunology and Transplantation Rega Institute for Medical Research Leuven Belgium

Lee Kong Chian School of Medicine Nanyang Technological University Singapore Singapore

National Centre for Infectious Diseases Singapore Singapore

Organic Chemistry Department of Chemistry Faculty of Sciences University of Hamburg Hamburg Germany

The Institute for Glycomics Griffith University Southport QLD Australia

Viral Special Pathogens Branch Division of High Consequence Pathogens and Pathology Centers for Disease Control and Prevention Atlanta GA USA

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016347
003      
CZ-PrNML
005      
20231026110010.0
007      
ta
008      
231013s2023 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.antiviral.2023.105678 $2 doi
035    __
$a (PubMed)37494979
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Spengler, Jessica R $u Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: JSpengler@cdc.gov
245    10
$a Meeting report: 36th International Conference on Antiviral Research in Lyon, France - March 13-17, 2023 / $c JR. Spengler, K. Carter, L. Delang, D. Durantel, BB. Gowen, LJ. Herrero, B. Hurst, Z. Janeba, R. Jordan, D. Luo, C. Meier, J. Moffat, J. Rocha-Pereira, KL. Seley-Radtke, SR. Welch, LM. Schang
520    9_
$a The 36th International Conference on Antiviral Research (ICAR), sponsored by the International Society for Antiviral Research (ISAR), was held March 13-17, 2023, in Lyon, France, and concurrently through an interactive remote meeting platform. Here we provide a report summarizing the presentations at the 36th ICAR, including the ISAR speaker awards. We also detail special events, sessions, and additional awards conferred at the meeting. ICAR returned to in-person meetings in 2022, convening in Seattle, WA, USA. The 36th ICAR is the first in-person meeting of the society in Europe since the beginning of the COVID-19 pandemic, which restricted most events to virtual attendance to help mitigate the spread and subsequent public health impact of SARS-CoV-2. An exceptionally high number of registrants and record attendance at this year's ICAR, along with a vast array of demonstrable expertise in a variety of antiviral research-related fields, reflected a strong and growing antiviral research community committed to improving health outcomes from viral diseases, including SARS-CoV-2, and to future pandemic preparedness. This report highlights the breadth of expertise, quality of research, and notable advancements that were contributed by members of ISAR and other participants at the meeting. ICAR aims to continue to provide a platform for sharing information, fostering collaborations, and supporting trainees in the field of antiviral research. The 37th ICAR will be held in Gold Coast, Australia, May 20-24, 2024.
650    _2
$a lidé $7 D006801
650    12
$a antivirové látky $x farmakologie $x terapeutické užití $7 D000998
650    12
$a COVID-19 $7 D000086382
650    _2
$a železo-dextranový komplex $7 D007505
650    _2
$a pandemie $7 D058873
650    _2
$a SARS-CoV-2 $7 D000086402
655    _2
$a kongresy $7 D016423
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Carter, Kara $u Evotec US, Princeton, NJ, USA
700    1_
$a Delang, Leen $u Laboratory of Virology and Chemotherapy, Mosquito Virology Team, KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Leuven, Belgium
700    1_
$a Durantel, David $u Centre International de Recherche en Infectiologie (CIRI), Inserm_U1111, CNRS_UMR5308, Université Claude Bernard Lyon 1, F-69007, Lyon, France
700    1_
$a Gowen, Brian B $u Institute for Antiviral Research and Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, UT, USA
700    1_
$a Herrero, Lara J $u The Institute for Glycomics, Griffith University, Southport, QLD, Australia
700    1_
$a Hurst, Brett $u Institute for Antiviral Research and Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, UT, USA
700    1_
$a Janeba, Zlatko $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, Prague, Czech Republic
700    1_
$a Jordan, Robert $u Global Health Discovery & Translational Sciences, Bill & Melinda Gates Foundation, Seattle, WA, USA
700    1_
$a Luo, Dahai $u Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore; National Centre for Infectious Diseases, Singapore, Singapore
700    1_
$a Meier, Chris $u Organic Chemistry, Department of Chemistry, Faculty of Sciences, University of Hamburg, Hamburg, Germany
700    1_
$a Moffat, Jennifer $u Department of Microbiology & Immunology, SUNY Upstate Medical University, Syracuse, NY, USA
700    1_
$a Rocha-Pereira, Joana $u KU Leuven-Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium
700    1_
$a Seley-Radtke, Katherine L $u Department of Chemistry & Biochemistry, University of Maryland, Baltimore County, Baltimore, MD, USA
700    1_
$a Welch, Stephen R $u Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA
700    1_
$a Schang, Luis M $u Baker Institute and Department of Microbiology and Immunology, Cornell University, Ithaca, NY, USA
773    0_
$w MED00000480 $t Antiviral research $x 1872-9096 $g Roč. 217, č. - (2023), s. 105678
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37494979 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026110004 $b ABA008
999    __
$a ok $b bmc $g 2000081 $s 1202709
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 217 $c - $d 105678 $e 20230724 $i 1872-9096 $m Antiviral research $n Antiviral Res $x MED00000480
LZP    __
$a Pubmed-20231013

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...